• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终末产物的膳食摄入量与肝胆癌风险:一项多国队列研究。

Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study.

作者信息

Mayén Ana-Lucia, Aglago Elom K, Knaze Viktoria, Cordova Reynalda, Schalkwijk Casper G, Wagner Karl-Heinz, Aleksandrova Krasimira, Fedirko Veronika, Keski-Rahkonen Pekka, Leitzmann Michael F, Katzke Verena, Srour Bernard, Schulze Matthias B, Masala Giovanna, Krogh Vittorio, Panico Salvatore, Tumino Rosario, Bueno-de-Mesquita Bas, Brustad Magritt, Agudo Antonio, Chirlaque López María Dolores, Amiano Pilar, Ohlsson Bodil, Ramne Stina, Aune Dagfinn, Weiderpass Elisabete, Jenab Mazda, Freisling Heinz

机构信息

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Department of Nutritional Sciences, University of Vienna, Vienna, Austria.

出版信息

Int J Cancer. 2021 Apr 25;149(4):854-64. doi: 10.1002/ijc.33612.

DOI:10.1002/ijc.33612
PMID:33899229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8360042/
Abstract

Advanced glycation endproducts (AGEs) may contribute to liver carcinogenesis because of their proinflammatory and prooxidative properties. Diet is a major source of AGEs, but there is sparse human evidence on the role of AGEs intake in liver cancer etiology. We examined the association between dietary AGEs and the risk of hepatobiliary cancers in the European Prospective Investigation into Cancer and Nutrition prospective cohort (n = 450 111). Dietary intake of three AGEs, N -[carboxymethyl]lysine (CML), N -[1-carboxyethyl]lysine (CEL) and N -[5-hydro-5-methyl-4-imidazolon-2-yl]-ornithine (MG-H1), was estimated using country-specific dietary questionnaires linked to an AGEs database. Cause-specific hazard ratios (HR) and their 95% confidence intervals (CI) for associations between dietary AGEs and risk of hepatocellular carcinoma (HCC), gallbladder and biliary tract cancers were estimated using multivariable Cox proportional hazard regression. After a median follow-up time of 14.9 years, 255 cases of HCC, 100 cases of gallbladder cancer and 173 biliary tract cancers were ascertained. Higher intakes of dietary AGEs were inversely associated with the risk of HCC (per 1 SD increment, HR-  = 0.87, 95% CI: 0.76-0.99, HR-  = 0.84, 95% CI: 0.74-0.96 and HR-  = 0.84, 95% CI: 0.74-0.97). In contrast, positive associations were observed with risk of gallbladder cancer (per 1 SD, HR-  = 1.28, 95% CI: 1.05-1.56, HR-  = 1.17; 95% CI: 0.96-1.40, HR-  = 1.27, 95% CI: 1.06-1.54). No associations were observed for cancers of the intra and extrahepatic bile ducts. Our findings suggest that higher intakes of dietary AGEs are inversely associated with the risk of HCC and positively associated with the risk of gallbladder cancer.

摘要

晚期糖基化终末产物(AGEs)可能因其促炎和促氧化特性而导致肝癌发生。饮食是AGEs的主要来源,但关于AGEs摄入在肝癌病因学中的作用,人类证据稀少。我们在欧洲癌症与营养前瞻性调查队列(n = 450111)中研究了饮食中AGEs与肝胆癌风险之间的关联。使用与AGEs数据库相关联的特定国家饮食问卷估计了三种AGEs(N - [羧甲基]赖氨酸(CML)、N - [1 - 羧乙基]赖氨酸(CEL)和N - [5 - 羟基 - 5 - 甲基 - 4 - 咪唑啉 - 2 - 基] - 鸟氨酸(MG - H1))的饮食摄入量。使用多变量Cox比例风险回归估计饮食中AGEs与肝细胞癌(HCC)、胆囊癌和胆管癌风险之间关联的病因特异性风险比(HR)及其95%置信区间(CI)。在中位随访时间14.9年后,确定了255例HCC病例、100例胆囊癌病例和173例胆管癌病例。饮食中AGEs摄入量较高与HCC风险呈负相关(每增加1个标准差,HR = 0.87,95% CI:0.76 - 0.99,HR = 0.84,95% CI:0.74 - 0.96,HR = 0.84,95% CI:0.74 - 0.97)。相反,观察到与胆囊癌风险呈正相关(每增加1个标准差,HR = 1.28,95% CI:1.05 - 1.56,HR = 1.17;95% CI:0.96 - 1.40,HR = 1.27,95% CI:1.06 - 1.54)。肝内和肝外胆管癌未观察到关联。我们的研究结果表明,饮食中AGEs摄入量较高与HCC风险呈负相关,与胆囊癌风险呈正相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691a/8360042/88a2c2ac50ee/IJC-149-854-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691a/8360042/88a2c2ac50ee/IJC-149-854-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691a/8360042/88a2c2ac50ee/IJC-149-854-g001.jpg

相似文献

1
Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study.晚期糖基化终末产物的膳食摄入量与肝胆癌风险:一项多国队列研究。
Int J Cancer. 2021 Apr 25;149(4):854-64. doi: 10.1002/ijc.33612.
2
Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.饮食中晚期糖基化终产物的摄入量与血浆和尿液中晚期糖基化终产物水平升高有关:CODAM 研究。
Clin Nutr. 2018 Jun;37(3):919-925. doi: 10.1016/j.clnu.2017.03.019. Epub 2017 Mar 23.
3
Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults.欧洲成年人饮食中晚期糖基化终产物(AGEs)的摄入量与体重变化。
Eur J Nutr. 2020 Oct;59(7):2893-2904. doi: 10.1007/s00394-019-02129-8. Epub 2019 Nov 7.
4
Dietary glycation compounds - implications for human health.饮食糖化化合物 - 对人类健康的影响。
Crit Rev Toxicol. 2024 Sep;54(8):485-617. doi: 10.1080/10408444.2024.2362985. Epub 2024 Aug 16.
5
Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.膳食晚期糖基化终产物与欧洲癌症与营养前瞻性调查(EPIC)研究中的结直肠癌风险。
Nutrients. 2021 Sep 8;13(9):3132. doi: 10.3390/nu13093132.
6
Dietary advanced glycation end products intake, genetic predisposition and risk of coronary heart disease: a prospective study.膳食晚期糖基化终产物摄入量、遗传易感性与冠心病风险:一项前瞻性研究。
Eur J Nutr. 2025 Mar 10;64(3):114. doi: 10.1007/s00394-025-03632-x.
7
Higher dietary advanced glycation products intake is associated with increased risk of dementia, independent from genetic predisposition.较高的膳食晚期糖基化终产物摄入与痴呆风险增加相关,与遗传易感性无关。
Clin Nutr. 2023 Sep;42(9):1788-1797. doi: 10.1016/j.clnu.2023.08.006. Epub 2023 Aug 8.
8
Habitual intake of advanced glycation endproducts is not associated with worse insulin sensitivity, worse beta cell function, or presence of prediabetes or type 2 diabetes: The Maastricht Study.习惯性摄入晚期糖基化终产物与较差的胰岛素敏感性、较差的β细胞功能、以及前驱糖尿病或 2 型糖尿病的发生无关:马斯特里赫特研究。
Clin Nutr. 2023 Aug;42(8):1491-1500. doi: 10.1016/j.clnu.2023.05.021. Epub 2023 May 29.
9
The contribution of dietary advanced glycation end-products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study.饮食中晚期糖基化终产物的贡献和遗传风险在炎症性肠病发展中的作用:一项前瞻性队列研究。
Aliment Pharmacol Ther. 2024 Oct;60(8):1075-1086. doi: 10.1111/apt.18218. Epub 2024 Aug 23.
10
High dietary glycemic load is associated with higher concentrations of urinary advanced glycation endproducts: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) Study.高膳食血糖负荷与尿晚期糖基化终产物浓度升高有关:马斯特里赫特糖尿病和动脉粥样硬化队列(CODAM)研究。
Am J Clin Nutr. 2019 Aug 1;110(2):358-366. doi: 10.1093/ajcn/nqz119.

引用本文的文献

1
Association of Dietary Advanced Glycation End Products with Overall and Site-Specific Cancer Risk and Mortality: A Systematic Review and Meta-Analysis.膳食晚期糖基化终产物与总体及特定部位癌症风险和死亡率的关联:一项系统评价和荟萃分析
Nutrients. 2025 May 10;17(10):1638. doi: 10.3390/nu17101638.
2
Dietary advanced glycation end-products (dAGEs) are not associated with the risk of cancer incidence. A systematic review and meta-analysis of prospective cohort studies.膳食晚期糖基化终产物(dAGEs)与癌症发病风险无关。一项前瞻性队列研究的系统评价和荟萃分析。
Food Sci Nutr. 2024 Aug 11;12(10):7788-7797. doi: 10.1002/fsn3.4396. eCollection 2024 Oct.
3

本文引用的文献

1
Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults.欧洲成年人饮食中晚期糖基化终产物(AGEs)的摄入量与体重变化。
Eur J Nutr. 2020 Oct;59(7):2893-2904. doi: 10.1007/s00394-019-02129-8. Epub 2019 Nov 7.
2
Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products.非酒精性脂肪性肝病的发生和发展:晚期糖基化终产物的作用。
Int J Mol Sci. 2019 Oct 11;20(20):5037. doi: 10.3390/ijms20205037.
3
Survival analysis: part II - applied clinical data analysis.
Correlation of serum IGF-1, AGEs and their receptors with the risk of colorectal cancer in patients with type 2 diabetes mellitus.
2型糖尿病患者血清胰岛素样生长因子-1、晚期糖基化终末产物及其受体与结直肠癌风险的相关性
Front Oncol. 2023 Feb 20;13:1125745. doi: 10.3389/fonc.2023.1125745. eCollection 2023.
4
Receptor of advanced glycation end-products axis and gallbladder cancer: A forgotten connection that we should reconsider.晚期糖基化终产物受体轴与胆囊癌:一个被遗忘的联系,我们应该重新考虑。
World J Gastroenterol. 2022 Oct 21;28(39):5679-5690. doi: 10.3748/wjg.v28.i39.5679.
5
Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study.20多个解剖部位的晚期糖基化终产物(AGEs)膳食摄入量与癌症风险:一项多国队列研究。
Cancer Commun (Lond). 2022 Oct;42(10):1041-1045. doi: 10.1002/cac2.12343. Epub 2022 Aug 4.
6
The RAGE/multiligand axis: a new actor in tumor biology.RAGE/多配体轴:肿瘤生物学的新角色。
Biosci Rep. 2022 Jul 29;42(7). doi: 10.1042/BSR20220395.
7
Dietary advanced glycation end products and cancer risk in Japan: From the Takayama study.膳食晚期糖基化终产物与日本癌症风险:来自高山研究。
Cancer Sci. 2022 Aug;113(8):2839-2848. doi: 10.1111/cas.15455. Epub 2022 Jun 25.
8
A 4-Week Diet Low or High in Advanced Glycation Endproducts Has Limited Impact on Gut Microbial Composition in Abdominally Obese Individuals: The deAGEing Trial.四周低糖或高糖饮食对腹型肥胖个体肠道微生物组成的影响有限:deAGEing 试验。
Int J Mol Sci. 2022 May 10;23(10):5328. doi: 10.3390/ijms23105328.
9
A 4-week high-AGE diet does not impair glucose metabolism and vascular function in obese individuals.四周高 AGE 饮食不会损害肥胖个体的葡萄糖代谢和血管功能。
JCI Insight. 2022 Mar 22;7(6):e156950. doi: 10.1172/jci.insight.156950.
10
Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer.膳食中晚期糖基化终产物(AGEs)的摄入量与结直肠癌患者的死亡率。
Nutrients. 2021 Dec 10;13(12):4435. doi: 10.3390/nu13124435.
生存分析:第二部分 - 应用临床数据分析。
Korean J Anesthesiol. 2019 Oct;72(5):441-457. doi: 10.4097/kja.19183. Epub 2019 May 17.
4
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Elevated Levels of the Reactive Metabolite Methylglyoxal Recapitulate Progression of Type 2 Diabetes.活性代谢产物甲基乙二醛水平升高可再现 2 型糖尿病的进展。
Cell Metab. 2018 Apr 3;27(4):926-934.e8. doi: 10.1016/j.cmet.2018.02.003. Epub 2018 Mar 15.
7
An insight on the association of glycation with hepatocellular carcinoma.糖化与肝细胞癌关系的研究进展。
Semin Cancer Biol. 2018 Apr;49:56-63. doi: 10.1016/j.semcancer.2017.06.005. Epub 2017 Jun 19.
8
Age dependent accumulation patterns of advanced glycation end product receptor (RAGE) ligands and binding intensities between RAGE and its ligands differ in the liver, kidney, and skeletal muscle.晚期糖基化终末产物受体(RAGE)配体的年龄依赖性积累模式以及RAGE与其配体之间的结合强度在肝脏、肾脏和骨骼肌中存在差异。
Immun Ageing. 2017 Jun 5;14:12. doi: 10.1186/s12979-017-0095-2. eCollection 2017.
9
International incidence and mortality trends of liver cancer: a global profile.全球肝癌发病率和死亡率趋势:国际概况。
Sci Rep. 2017 Mar 31;7:45846. doi: 10.1038/srep45846.
10
Hormetic modulation of hepatic insulin sensitivity by advanced glycation end products.晚期糖基化终产物对肝脏胰岛素敏感性的 hormetic 调节作用 。 (注:“hormetic”这个词在医学领域可能有特定专业含义,这里直接保留英文未翻译,需结合更多专业知识准确理解。)
Mol Cell Endocrinol. 2017 May 15;447:116-124. doi: 10.1016/j.mce.2017.02.035. Epub 2017 Feb 24.